You are here : Home / All Sectors / Agri / Agriculture / NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Intrinsic Value | Fundamental Analysis

Returns | 1W : -4.8% , 1M : 7.1%,1Y : 47.3%
BOM : 537291     NSE : NATHBIOGEN    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : Average [>25% and <50%]
Apr 20,2021
Price(EOD): Rs. 321.85
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 611.52 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
NATH BIOGENES (INDIA) -4.8% 7.1% 47.3%
BOMBAY BURMAH TRADING CORPORATION -4% -1% 37.9%
KAVERI SEED COMPANY 8.2% 15.6% 51.5%
VENKYS (INDIA) -2.7% -4% 32.7%
GOODRICKE GROUP 0.5% -10.4% 37%
JK AGRI GENETICS -5.4% 2.6% 35.5%
SHREE GANESH BIOTECH (INDIA) -0.7% -0.7% -27.4%
DHUNSERI TEA & INDUSTRIES 0.5% -7% 81%
HARRISONS MALAYALAM -0.5% -10% 130.3%

FUNDAMENTAL ANALYSIS OF NATH BIOGENES (INDIA)

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than NATH BIOGENES (INDIA) Premium


VALUATION OF NATH BIOGENES (INDIA)

 
Valuation Score
RatioValue
P/E
P/B
P/S
12.12
P/E Calculated based on EPS of 26.56
[ Mar2020 - Standalone Results ]

1.1
P/B Calculated based on Book Value of 293.42
[ Mar2020 - Standalone Results ]

1.98
P/S Calculated based on Revenues of 309.031 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than NATH BIOGENES (INDIA) Premium


FAIR VALUE OF NATH BIOGENES (INDIA)

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
56%
52%
96%

SHARE PRICE MOMENTUM OF NATH BIOGENES (INDIA)

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.13
0.11
0.07
0.1
-
-
-
-
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
36.31 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
51.93%
24.95%
43.44%
40.9%
8.99%
20.33%
11.71%
8.84%
QtrlyTrend
8
Latest Qtr: Dec2020

NATH BIOGENES (INDIA) related INDICES

BSE Indices1W1M1Y
S&P BSE SMALL CAP -0.1% 0.3% 91.4%
S&P BSE MIDSMALLCAP -0.3% -0.3% 79.7%
S&P BSE ALLCAP -1.1% -2.1% 60%
S&P BSE FMCG -1.3% 3.5% 16.1%
No NSE index found

FAQ [Frequently Asked Questions]


Is NATHBIOGEN good for long term investment?

As on 20-Apr-2021, the Fundamentals of NATHBIOGEN are Average and hence you can wait for the results to improve to invest for long term ! See Financial Performance of NATH BIOGENES (INDIA) . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is NATHBIOGEN UnderValued or OverValued?

As on 20-Apr-2021, NATHBIOGEN is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of NATHBIOGEN ?

As on 20-Apr-2021, the Intrinsic Value of NATHBIOGEN is Rs. 205.76 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 205.76
Fair Value [Median EV / Sales Model] : Rs. 211.10
Fair Value [Median Price / Sales Model] : Rs. 164.27
Median Fair Value of NATHBIOGEN : Rs. 205.76

Is NATHBIOGEN trading at a Premium or Discount?

As on 20-Apr-2021, NATHBIOGEN is trading at a Premium of 56% based on the Median Intrinsic Value!

Is it right time to buy NATHBIOGEN shares?

As on 20-Apr-2021, NATHBIOGEN is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of NATHBIOGEN?

Check out Financials of Industry Peers using below links:
Financials of BOMBAY BURMAH TRADING CORPORATION LTD
Financials of KAVERI SEED COMPANY LTD
Financials of VENKYS (INDIA) LTD
Financials of GOODRICKE GROUP LTD
Financials of JK AGRI GENETICS LTD
Financials of SHREE GANESH BIOTECH (INDIA) LTD
Financials of DHUNSERI TEA & INDUSTRIES LTD
Financials of HARRISONS MALAYALAM LTD

What are the Frequent Comparisons with NATHBIOGEN?

NATH BIOGENES (INDIA) LTD vs BOMBAY BURMAH TRADING CORPORATION LTD vs KAVERI SEED COMPANY LTD
NATH BIOGENES (INDIA) LTD vs BOMBAY BURMAH TRADING CORPORATION LTD vs VENKYS (INDIA) LTD
NATH BIOGENES (INDIA) LTD vs BOMBAY BURMAH TRADING CORPORATION LTD vs GOODRICKE GROUP LTD
NATH BIOGENES (INDIA) LTD vs BOMBAY BURMAH TRADING CORPORATION LTD vs JK AGRI GENETICS LTD
NATH BIOGENES (INDIA) LTD vs BOMBAY BURMAH TRADING CORPORATION LTD vs SHREE GANESH BIOTECH (INDIA) LTD
NATH BIOGENES (INDIA) LTD vs BOMBAY BURMAH TRADING CORPORATION LTD vs DHUNSERI TEA & INDUSTRIES LTD
NATH BIOGENES (INDIA) LTD vs BOMBAY BURMAH TRADING CORPORATION LTD vs HARRISONS MALAYALAM LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z